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Independent phenotypic plasticity axes define
distinct obesity sub-types
Chih-Hsiang Yang 1,2,26, Luca Fagnocchi 1,26, Stefanos Apostle1, Vanessa Wegert1,2,
Salvador Casaní-Galdón 3, Kathrin Landgraf 4, Ilaria Panzeri 1,2, Erez Dror2, Steffen Heyne2,5,
Till Wörpel2, Darrell P. Chandler1, Di Lu1, Tao Yang 1, Elizabeth Gibbons6, Rita Guerreiro6, Jose Bras6,
Martin Thomasen7, Louise G. Grunnet7,8, Allan A. Vaag7,8,14, Linn Gillberg 9, Elin Grundberg 10,
Ana Conesa11,12, Antje Körner 4,13, PERMUTE* and J. Andrew Pospisilik 1,2 ✉
Studies in genetically ‘identical’ individuals indicate that as much as 50% of complex trait variation cannot be traced to genetics
or to the environment. The mechanisms that generate this ‘unexplained’ phenotypic variation (UPV) remain largely unknown.
Here, we identify neuronatin (NNAT) as a conserved factor that buffers against UPV. We find that Nnat deficiency in isogenic
mice triggers the emergence of a bi-stable polyphenism, where littermates emerge into adulthood either ‘normal’ or ‘overgrown’.
Mechanistically, this is mediated by an insulin-dependent overgrowth that arises from histone deacetylase (HDAC)-dependent
β-cell hyperproliferation. A multi-dimensional analysis of monozygotic twin discordance reveals the existence of two patterns of
human UPV, one of which (Type B) phenocopies the NNAT-buffered polyphenism identified in mice. Specifically, Type-B monozygotic co-twins exhibit coordinated increases in fat and lean mass across the body; decreased NNAT expression; increased
HDAC-responsive gene signatures; and clinical outcomes linked to insulinemia. Critically, the Type-B UPV signature stratifies
both childhood and adult cohorts into four metabolic states, including two phenotypically and molecularly distinct types of obesity.

B

iomedical research is driven by a 100-year-old dogma that
phenotype results from the additive effects of genes and environment1,2. Since the 1920s, a persistent and compelling body
of evidence has argued for the existence of an additional dimension
of phenotypic variation not explained by genetics or the environment3. Klaus Gärtner’s 30-year effort to standardize rodent models,
for instance, aptly demonstrated that continuously inbred animals
raised under stringent, standardized conditions continue to exhibit
a remarkable degree of UPV4. Potential mediators of UPV include
residual genetic variation5, mosaic genetic variation, gene–gene and
gene–environment interactions (non-additive modifier effects),
intergenerational and developmental programming and probabilistic mechanisms such as those underpinning organismal polyphenisms and meta-stable epiallele control6,7. For precision medicine,
our limited understanding of UPV represents a massive source
of untapped potential: estimates from trait concordance analyses
between co-twins8 suggest that UPV is responsible for ~50% of relevant complex trait variation9–15.
Deep literature on epigenetics demonstrates the existence of
highly conserved, molecular machinery that stabilize transiently
plastic transcriptional units into highly stable ON or OFF transcriptional (phenotypic) outputs between isogenic cells and organisms16,17. Literature on position-effect variegation for instance,
highlights the existence of hundreds of such genomic loci whose

expression output is transiently probabilistic in early development
and ultimately deterministic (ON or OFF) despite originating in the
same tissue of the same individual in the same environment, without change in the underlying DNA sequence. These studies indicate that a fraction of UPV is likely not due to random biological
‘noise’. The existence of alternate but distinct phenotypic sub-states,
as opposed to random phenotypic noise, carries profound implications for precision medicine. While not typically interpreted in this
fashion, the original work that pioneered the discovery of epigenetic silencing mechanisms in yeast and Drosophila, demonstrate a
complex regulatory network exists sufficient to underpin organismal UPV18–20, at least as they pertain to single reporter loci. While
it is now clear that hormones and chromatin pathways can regulate UPV, we know very little about the molecular machinery that
buffers against phenotypic variation and confine developmental/
phenotypic outcomes to a specific range for any given gene–environment context. Notably, while conceptually related, the regulation of robustness is thought to be distinct from that of phenotypic
plasticity21–23. For instance, plasticity regulators inherently mediate
gene–environment interaction; robustness factors prevent phenotypic variation upon environmental perturbations22,23.
One challenge when studying UPV (and phenotypic variability
in general) is the large number of experimental animals required
to statistically test and validate variance heterogeneity effects
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(differences in distribution or variance)24,25. Experimental designs
must factor in (and rule out) confounds such as paternal, maternal and litter-size effects26–29. Most biomedical experiments are not
designed or powered for such analyses. Using proper design and
power, we recently demonstrated that Trim28 is a robustness factor
in mice; Trim28 buffers against UPV30. This work suggested Nnat
and imprinted gene network 1 (IGN1) as potential mediators of
Trim28-dependent UPV control.
Nnat is a paternally expressed imprinted gene that encodes for
a transmembrane proteolipid of the endoplasmic reticulum (ER).
It was first described as a developmentally regulated gene of the
embryonic brain31,32, but is also widely expressed and associated
with energy homeostasis across tissues33. Nnat expression is necessary for proper glucose-stimulated insulin secretion in differentiated pancreatic β-cells34–36, for adipogenesis and glucose disposal
in adipocytes37–39, appetite in the hypothalamus40 and for energy
expenditure and food intake41,42. It remains unclear whether any of
these functions play a causal role in the emergence of UPV or mammalian polyphenism.
Here, we find that: (1) Nnat insufficiency triggers an overgrowth
polyphenism (increased fat and lean mass) distinct and independent of Trim28-buffered UPV43; (2) Nnat- and Trim28-buffering
mechanisms are distinct; (3) Nnat-buffered overgrowth is driven
by cell-autonomous β-cell hyperplasia and can be abrogated by
chemical intervention; and (4) that β-cell hyperplasia depends on
HDAC-dependent transcriptional rewiring. Expanding our analysis
to humans, we identify at least two different, recurrent patterns of
human UPV among monozygotic (MZ) co-twins (Type A and Type B).
Of note, Type-B UPV is associated with reduced NNAT gene expression and shares similar molecular and metabolic features with the
mouse model. Critically, a Type-B UPV gene expression signature
stratifies human populations into distinct molecular/metabolic
sub-types and separates two types of obesity. The data reported here
therefore identify NNAT as a critical regulator of mammalian UPV.

Results

Nnat buffers an overgrowth polyphenism. To unequivocally test
Nnat’s role as a robustness factor and understand the physiological mechanisms by which it buffers against UPV, we intercrossed
highly inbred B6 congenic Nnat knockout males (B6.Nnat+/-p)
with wild-type (WT) FVBN/J females, generating large cohorts
of Nnat-deficient (Nnat+/-p) and WT littermate matched F1 controls. This breeding scheme maximally restricted inter-individual
genetic variation (through isogenicity) while maintaining substantial genome-wide heterozygosity. To minimize litter-size effects
(variation attributable to differences in in utero/early-life sufficiency), we used offspring from litters of 9–12 pups and tightly controlled husbandry, environment and housing density. Nnat+/-p mice
emerged into adulthood in one of two non-overlapping (bi-stable)
phenotypic forms: either unremarkable (Nnat+/-p-Light) or overgrown relative to WT and Nnat+/-p-Light animals (Nnat+/-p-Heavy).
Overgrowth was characterized by coordinated increases in fat and
lean mass (Fig. 1a,b and Extended Data Fig. 1a), which is distinct
from the previously reported Trim28-buffered polyphenism and
from other reports of heterogeneity using the Nnat+/-p allele36,41–43.
Nnat+/-p-Heavy animals were ~50% heavier than both their WT
and Nnat+/-p-Light littermates and had increased white adipose
tissue, spleen, pancreas, kidney, liver and heart mass (Fig. 1c).
Notably, not all tissues were enlarged. Skeletal muscle, brown
adipose tissue and brain masses were unchanged or minimally
reduced in Nnat+/-p-Heavy animals (Fig. 1c, right). Skeletal morphometry confirmed a larger skeletal frame in the Nnat+/-p-Heavy
morphs (Fig. 1d). Given that the Nnat+/-p-Light and Nnat+/-p-Heavy
animals are isogenic, raised in highly standardized environments
and reproducibly observed within litters and across multiple
independent breeding pairs, these data demonstrate that Nnat
Nature Metabolism | VOL 4 | September 2022 | 1150–1165 | www.nature.com/natmetab
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acts to buffer against bi-stable overgrowth potential. Thus, Nnat
deficiency triggers a polyphenism, characterized by probabilistic
overgrowth and obesity.
We validated these findings in several ways. First, deleting
the imprinted maternal Nnat allele, which generates isogenic
Nnat-deletion mutants albeit with normal Nnat expression, did
not trigger overgrowth in the same line (Nnat-m/+; Extended Data
Fig. 1b,c). Second, we tested and observed phenotypic bi-stability
in two independent mouse houses and after surviving rederivations independently from cryopreserved embryos and sperm
(MPI-IE, Germany; Fig. 1a and Extended Data Fig. 1a; and VAI,
USA; Extended Data Fig. 1d,e). Third, we observed bi-stability
over dozens of generations, despite exclusively using Nnat+/-p-Light
animals as fathers and naive WT C57BL/6J females for continuous
backcrossing. Nnat deletion is clear in both Light and Heavy morphs
at the DNA and messenger RNA levels (Extended Data Fig. 1f).
Thus, Nnat+/-p-triggered overgrowth is robust across distinct environments and in vitro rederivation protocols. To the best of our
knowledge, these data represent an unprecedented demonstration
of mammalian polyphenism in a genetic context of substantial
genome-wide heterozygosity (F1 hybrids as opposed to congenic
lines). They rule out genome-wide homozygosity as a precondition
for mammalian polyphenism.
One of the key challenges in deciphering mechanisms that regulate UPV is our limited understanding of the fidelity with which
UPV effects are manifest across disparate experimental conditions. We therefore used genetic epistasis to test whether Trim28
and Nnat-buffered polyphenisms are simply context-specific forms
of the same process. We crossed FVB.Trim28+/D9 (maternal) and
B6.Nnat+/-p (paternal) lines to generate B6/FVB F1 hybrid offspring
that were either WT at both loci, mutant only for Trim28+/D9, mutant
only for Nnat+/-p or mutant for both alleles in the very same genetic
background, parental and in utero contexts. Trim28+/D9 offspring
(WT for Nnat) showed bi-stable growth trajectories culminating in
a bi-stable obesity, whereas solely their Nnat+/-p siblings (WT for
Trim28) showed distinct early bifurcating overgrowth trajectories
(Fig. 1e). These data indicated the Trim28- and Nnat-induced polyphenisms are at least partially distinct. Notably and in the true test
of independence, double-mutant (Nnat+/-p;Trim28+/D9) littermates
showed tri-stable phenotypic trajectories (Fig. 1e and Extended
Data Fig. 1g), where genetically and context-matched animals
exhibited a light (WT-like), obese or overgrown phenotype.
Trim28 expression was unchanged among WT, Nnat+/-p-Light and
Nnat+/-p-Heavy animals (Extended Data Fig. 1h). The single-mutant
analyses also indicate that Nnat-mediated buffering is agnostic to
the loss of maternal Trim28; and that Trim28-dependent buffering
is agnostic to the loss of paternal Nnat+/−. This data shows unprecedented genetic proof of tri-stable phenotypic potential in mammals
and demonstration of independence and additivity of distinct polyphenisms. The data also indicate that the probabilistic ‘obese’ and
‘heavy’ morphs triggered by loss of Trim28 and Nnat (respectively)
are distinct and they demonstrate that the mammalian genome has
the capacity to canalize three reproducible and discrete developmental trajectories.
Nnat loss triggers bi-stable β-cell hyperplasia. Previous work
suggested that Nnat deletion causes a stochastic obesity (B6
background; several groups/vivaria42,43) and partially penetrant,
early-life growth restriction that is alleviated in later life through
increased food intake (129S2/Sv background; one group41). To capture early growth kinetics of the Nnat+/-p-Light and Nnat+/-p-Heavy
animals, we tattooed animals at birth and tracked body composition. Nnat+/-p-Light and Nnat+/-p-Heavy animals exhibited comparable birth weights (Extended Data Fig. 2a), but Nnat+/-p-Heavy
morphs initiated the overgrowth developmental trajectory just
after 4 weeks of age (Fig. 1e and Extended Data Fig. 2b; top and
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Fig. 1 | Paternal Nnat deletion triggers a bi-stable epigenetic overgrowth in mice. a, Body composition shown for 16-week-old F1 male progeny from
Nnat+/-p × FVBN/J crosses. Contour plots highlighted main clusters identified by Gaussian finite mixture modeling. b, Representative picture presented for
Nnat+/p isogenic morphs and WT littermates. c, Organ masses were measured from Nnat+/p colony. Each group had at least eight animals. *Adjusted P ≤ 0.05,
as assessed by one-sided Tukey’s multiple comparisons test, comparing Nnat+/p-Heavy and Nnat+/p-Light littermates. Specifically, gonadal white adipose tissue
(gWAT) P < 0.0001, subcutaneous white adipose tissue (sWAT) P < 0.0001, spleen P < 0.0001, pancreas P = 0.0019, kidney P = 0.0011, liver P < 0.0001 and
heart P < 0.0297. Data are presented as mean ± s.e.m. BAT, brown adipose tissue. d, The lumbar spine (L1–L5) length was measured for the Nnat+/p colony.
Each group had at least five animals. In all box-plots, the lower and upper hinges represent 25th and 75th percentiles. The upper/lower whiskers represent
largest/smallest observation less/greater than upper/lower hinge+1.5 × interquartile range (IQR). Central median represents 50% quantile. *Adjusted
P = 0.015) as assessed by one-sided Tukey’s multiple comparisons test. e, Body composition (fat and lean mass) was measured via EchoMRI for each F1 male
progeny at 4, 6, 8, 12 and 16 weeks from B6.Nnat+/-p × FVB.Trim28D9/+ crosses. Developmental trajectories according to the phenotypic groups were plotted
from 4 to 16 weeks. Each trajectory had at least four animals. Data are presented as mean ± s.e.m. *P ≤ 0.05 by Student’s t-test.

middle). The phenotypic bifurcation is distinct from that observed
in Trim28 mutant mice that bifurcate (toward lean or obese end
states) in early adulthood (8–12 weeks; Fig. 1e). To better understand the origins of phenotypic bifurcation, we measured food
intake and body composition changes of the Nnat+/-p animals
between 4 and 7 weeks of age. Of note, increases in lean and fat mass
were measurable several weeks before any detectable hyperphagia,
1152

arguing against hyperphagia as a driver of Nnat+/-p-associated overgrowth and adiposity (Extended Data Fig. 2b,c).
Clinically, overgrowth typically results from hyperactive growth
hormone (GH)/insulin-like growth factor (IGF) signaling. We found
no increase in GH, IGF1 or IGF2 (undetectable) in Nnat+/-p-Heavy
mice, suggesting non-canonical overgrowth (Extended Data Fig. 2d).
GH was slightly reduced in Nnat+/-p-Heavy mice at 4 weeks, but not
Nature Metabolism | VOL 4 | September 2022 | 1150–1165 | www.nature.com/natmetab
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significantly. Notably, plasma levels of insulin (a non-canonical activator of IGFR signaling) showed marked increases in Nnat+/-p-Heavy
animals simultaneously with overgrowth bifurcation (Extended
Data Fig. 2d), reaching an exceptional ~20-fold normal levels by 16
weeks of age (Fig. 2a).
We then analyzed morphology, function and turnover of the
pancreatic islet β-cell compartment, the primary source of insulin in the body. Nnat+/-p-Heavy mice showed marked increases in
β-cell mass (Fig. 2b and Extended Data Fig. 3a,b) relative to both
WT and Nnat+/-p-Light groups. Nnat+/-p-Heavy animals also showed
reduced insulin immunoreactivity (Fig. 2b), consistent with previous work showing that β-cell-specific loss of Nnat (in otherwise
normal developmental contexts) impairs insulin secretion and
storage36. Overall, Nnat+/-p-Heavy animals showed total pancreatic
insulin content ~2.5-fold higher than WT and Nnat+/-p-Light groups
(Extended Data Fig. 3c). Thus, Nnat deletion leads to distinct programming of β-cell mass in Nnat+/-p-Light and Nnat+/-p-Heavy mice.
Nnat+/-p-Heavy animals showed increased numbers of
Ki-67-positive β-cells in vivo relative to Nnat+/-p-Light animals
(Fig. 2c). No differences were observed in islet organization and
rates of cell death (TUNEL) (Extended Data Fig. 3d,e). We therefore
measured proliferation in islets ex vivo to validate these findings
and assess the stability and cell autonomy of the hyperproliferative
program. Increased β-cell proliferation was readily measurable in
Nnat+/-p-Heavy islets after 3 days of ex vivo equilibration culture and
after 2 days of 5-ethynyl-2'-deoxyuridine (EdU) incubation (Fig. 2d).
These findings indicated islet-autonomous hyperproliferative programming in Nnat+/-p-Heavy animals. No measurable differences
were observed in insulin release in both primary islets and reconstituted islet spheroids, under steady-state or glucose-stimulated conditions (Extended Data Fig. 3f–h). In line with these data, glucose
tolerance was largely normal in Nnat+/-p-Heavy animals despite the
marked hyperinsulinemia (Extended Data Fig. 3i). These data suggested that the overgrowth polyphenism is driven by an alternate
β-cell hyperplasia program.
Nnat+/-p triggered overgrowth is insulin-dependent. To test whether
probabilistic Nnat+/-p overgrowth is driven by β-cell hyperplasia and
resulting hyperinsulinemia, we artificially ‘clamped’ in vivo insulin
levels at equal levels across groups by injecting animals with a single
high-dose injection of streptozocin (STZ) to deplete the endogenous β-cell pool44 and implanting slow-release subcutaneous insulin
pellets to restore insulin sufficiency equally across animals (Fig. 2e).
Treatment was initiated at ~5 weeks of age in longitudinally tracked
cohorts. Animals initiating their Nnat+/-p-Heavy trajectory (defined
as a 3 g fat mass gain within 5 days) were randomly sorted into treatment or control groups. Notably and where parallel control cohorts
of Nnat+/-p-Heavy morphs gained ~15 g of fat and ~3 g of lean mass
beyond that of their WT and Nnat+/-p-Light siblings (Fig. 2f,g top;
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arrow from WT/crosshair), combination therapy completely abrogated this alternate phenotype, yielding lean and fat mass accumulations comparable to WT animals (Fig. 2f (bottom) and Extended
Data Fig. 3j). All treated animals completed normal growth trajectories, reaching healthy mature body mass levels of ~30 g (Fig. 2g).
Thus, Nnat+/-p-Heavy overgrowth is insulin-dependent.
The alternate β-cell hyperplasia program is HDAC-dependent.
To gain insight into the developmental switch driving β-cell hyperplasia in Nnat+/-p-Heavy morphs, we performed RNA-sequencing
(RNA-seq) on Nnat+/-p islets before and after the onset of detectable overgrowth bifurcation (3 and 6 weeks). Transcriptomes from
WT and Nnat+/-p-Light islets showed minimal differences (Extended
Data Fig. 4a), consistent with the phenotypic similarities between
the two genotypes. These data demonstrate that whole-body Nnat
deletion, by itself, is not sufficient to drive β-cell dysregulation
and imply that Nnat’s primary function is to buffer against phenotypic variation. In contrast, Nnat+/-p-Heavy samples showed major
transcriptional rewiring (Fig. 3a,b and Extended Data Fig. 4a).
Consistent with the observed hyperplasia, gene set enrichment analysis (GSEA) revealed upregulation of pathways and leading-edge
signatures associated with cell cycle (Cdk6, Ccnl2, Myc and Tp53),
proliferation (Wnt7a/b, Mapk13, Foxj1, Fos and Smad3) and growth
factor signaling (Egr1, Fgfr2 and Epn3) (Fig. 3b,c). Downregulated
factors included islet endocrine lineage hormone genes (Gcg and
Sst), ER-processing (Pdia3/4, Lman1/2, Rpn1/2, Hsp90b1, Dnajb9
and Ssr4) and protein export pathways (Spcs3, Srps and Sec61b/g)
(Fig. 3b,c). Unexpectedly, Nnat+/-p-Heavy islets showed upregulation
of a functionally disparate set of HDAC-responsive genes (Fig. 3c
and Extended Data Fig. 4b). This result was particularly noteworthy because histone acetylation dynamics have been implicated in
regulating insect polyphenisms45,46 and cell proliferation in cancer47.
To test whether HDAC regulation was causally linked to the overgrowth polyphenism, we first examined whether the HDAC transcriptional signatures were already present before the phenotypic
bifurcation. Notably, the 3-week RNA-seq data revealed that Nnat+/-p
islet transcriptomes definitively separate into Nnat+/-p-Light-like
or Nnat+/-p-Heavy-like clusters, before phenotypic distinctions are
detectable (Fig. 3d). Fully 60% of the variation in the RNA-seq dataset correlated with the same HDAC-responsive gene sets (Fig. 3e
and Extended Data Fig. 4c,d), indicating that the HDAC-associated
genes are fundamentally responsible for the phenotypic variation
in that moment of early life. The data also suggested that dysregulation of HDAC-responsive genes might cause the β-cell hyperproliferation phenotype in Nnat+/-p-Heavy animals. In either case,
HDAC-associated transcriptional rewiring precedes the phenotypic
bifurcation toward overgrowth.
Second, we cultured islets from the three genotype-phenotype
combinations with histone acetylase inhibitors (HATi) or histone

Fig. 2 | Nnat+/-p-overgrowth exhibits autonomous β-cell hyperplasia and hyperinsulinemia. a, Plasma insulin was measured from 16-week-old male
animals fasted for 6 h. Each group had at least 17 animals. ***Adjusted P ≤ 0.001, as assessed by one-sided Tukey’s multiple comparisons test. b,
Insulin-positive β-cells (brown) in Nnat+/-p pancreata were detected by immunohistochemistry staining. Scale bar, 250 µm. β-cell area was quantified
as percentage of the entire pancreas area. Each group had at least four animals. ***Adjusted P ≤ 0.001, as assessed by one-sided Tukey’s multiple
comparisons test. c, In vivo immunofluorescence was performed for proliferating β-cells (white arrows) in primary islets from 16-week-old animals (red,
insulin; blue, DAPI; green, Ki-67). Scale bar, 100 µm. Ki-67+ β-cells were quantified and each group had at least 11 islets. ***Adjusted P ≤ 0.001, as assessed
by one-sided Tukey’s multiple comparisons test. DAPI, 4,6-diamidino-2-phenylindole. d, Ex vivo immunofluorescence was performed for proliferating
β-cells by EdU-incorporation. Size-matched primary islets from 5–6-week-old mice were cultured for 3 days before the EdU-incorporation assay (red,
insulin; blue, DAPI; green, EdU). Scale bar, 50 µm. EdU+ proliferating β-cells were quantified and each group had at least three islets. *Two-tailed P ≤ 0.05,
**two-tailed P ≤ 0.01, by Welch’s t-test. e, STZ (300 mg kg−1) was administered at 5 weeks of age when the Nnat+/-p-Heavy morphs first show signs of
accelerated weight gain. An equal number of subcutaneous (s.c.) insulin implants were administered after 5 days and 1 month after the STZ injection to all
STZ groups such that relative euglycemia was maintained. i.p., intraperitoneal. f, Lean and fat mass gained between 4 and 12 weeks of age for untreated
and STZ-treated Nnat+/-p littermates. Each group has at least three animals. INS, insulin. g, Body weight at termination highlights how Nnat+/-p-Heavy
mice fail to exhibit the overgrowth phenotype on combined STZ/insulin treatment. ***Adjusted P = 0.0001, as assessed by one-sided Tukey’s multiple
comparisons test. All data are presented as mean ± s.e.m.
Nature Metabolism | VOL 4 | September 2022 | 1150–1165 | www.nature.com/natmetab
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deacetylase inhibitors (HDACi) and tracked β-cell proliferation in vitro. Consistent with the data above, Nnat+/-p-Heavy islets
showed islet-autonomous β-cell hyperplasia at baseline (Fig. 3f).
Notably, HDACi treatment had no observable effect on WT and
Nnat+/-p-Light islets, but the treatment was sufficient to abrogate
Nnat+/-p-Heavy β-cell hyperplasia and return proliferation back to
WT levels (Fig. 3g). These data demonstrate that HDAC-sensitive
gene regulation is required for control of β-cell programming and
that Nnat’s buffering effect on phenotypic variation is mediated
through HDAC-responsive genes. HATi treatment, on the other
hand, had no effect on Nnat+/-p-Heavy β-cells (Fig. 3h), indicating a
necessary directionality to the regulatory process. Parallel treatment

of Nnat+/-p-Light β-cells showed no substantial regulation by either
inhibitor (Fig. 3f–h), further highlighting the specificity of the
HDAC-dependence. Thus, Nnat buffers against probabilistic phenotypic variation by preventing the activation of an HDAC-dependent
β-cell hyperplasia program.
Identification of phenotypic variation patterns in humans. The
foregoing data identify a Nnat-buffered axis that regulates probabilistic phenotypic variation. They demonstrate islet-autonomous
underpinnings, reproducible epigenome dysregulation and reversibility at in vitro and organismal scales, all of which are unprecedented findings for a mammalian polyphenism. Critically,
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Fig. 3 | HDAC mediates Nnat+/-p-driven β-cell hyperplasia. a, Heat map showing the expression of 552 differentially expressed genes (DEGs), defined as
Nnat+/-p-Heavy and Nnat+/-p-Light islets transcriptome, in the indicated animals. b, Volcano plot showing DEGs and highlighting the enriched or depleted
biologically relevant genes in Nnat+/-p-Heavy morphs. P values as assessed by negative binomial generalized linear model. c, The cytoscape plot of the
GSEA showed the enriched or depleted gene sets in Nnat+/-p-Heavy morphs. TFs, transcription factors. d, PCA demonstrated transcriptional similarity
of Nnat+/-p-Heavy-like at early stages (3 weeks) and Nnat+/-p-Heavy morphs at late stages (6 weeks) apart from Nnat+/-p-Light-like at early stages (3
weeks) and Nnat+/-p-Light morphs at late stages (6 weeks). e, Heat map shows HDAC gene set leading-edge gene expression in Nnat+/-p-Heavy-like
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they demonstrate epistatic independence and additivity with
Trim28-buffered phenotypic variation and thus identify two independent pathways for buffering alternate but bi-stable developmental trajectories and phenotypic heterogeneity.
In our previous work43, we found bimodal body mass distributions in large epidemiological cohorts, which raised the possibility
that bi-stable UPV might also exist in human populations. That
Nnat also buffers against bi-stable UPV again raised the question
Nature Metabolism | VOL 4 | September 2022 | 1150–1165 | www.nature.com/natmetab

about regulatory control and polyphenism potential in humans.
We therefore analyzed monozygotic (MZ) and dizygotic (DZ) twin
data8,48–52 for potential signatures of human UPV. While twin analyses do not rule out genetic and environmental trait variation5,53,54,
they substantially reduce these contributions. We performed
a high-dimensional analysis of 35 anthropometric traits measured across 153 MZ co-twin pairs from the TwinsUK’s Multiple
Tissue Human Expression Resource (MuTHER) cohort55–57. The
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high-dimensional approach served two purposes. First, the analysis
makes no assumptions about how UPV should manifest, but instead
hypothesizes that if regulated UPV systems exist in humans, their
consequences should be reproducible. Second, searching for
patterns of variation (twin discordance), as opposed to single-trait
discordances, reduces the impact of measurement errors in any
given trait.
We calculated co-twin trait discordance for each trait, which
included weight, height and fat and lean masses of the head, trunk
and limbs. Discordance between each trait was calculated for each
co-twin pair, setting the co-twin with the lower body mass index
(BMI) as the reference. Discordances for all traits were uniformly
lower in MZ co-twins than DZ co-twins, as expected (Extended
Data Fig. 5a). We then focused on MZ twin pairs and performed
a Uniform Manifold and Projection (UMAP) dimensional reduction58 on the 35 trait discordance × 153 co-twin pair matrix (Fig. 4a).
Notably, the analysis revealed four clusters or ‘patterns’ of phenotypic variation in the cohort: two were distinctly discordant clusters
(Type-A (green) and Type-B (red); Fig. 4a,b) and one was a central
concordant cluster (gray). An ‘Intermediate’ UPV cluster (orange)
was also identified tending toward Type-B UPV. Thus, we identified
four candidate patterns of human UPV.
The concordant cluster was characterized by minimal co-twin
trait discordance across all traits, which is what we would normally
expect from stereotypical ‘identical twins’ (Fig. 4b and Extended
Data Fig. 5b). Type-A UPV was characterized by increased fat masses
and a modest reduction of lean masses in heavier co-twins (dashed
green box; Fig. 4b and Extended Data Fig. 5b,c). By contrast, Type-B
UPV was characterized by increases in both fat and lean masses
across body parts in the heavier co-twin (Fig. 4b, dashed red box
and Extended Data Fig. 5b,c). These two patterns were distinct and
identified an inherently reproducible substructure in ‘non-genetic’
human variation. The findings provided a refined view of twin
variation relative to arbitrary BMI and obesity cutoffs59,60 (Fig. 4b;
for example ‘BMI’ and ‘obesity’ discordance top annotations). No
differences were observed in mean height or height discordance
across clusters (Extended Data Fig. 5b,d) and repeat analysis using
height-adjusted trait discordances captured the same fundamental
UPV patterns (Extended Data Fig. 5e). Notably, we also analyzed
genotyping data across the individuals of our four identified UPV
groups of MuTHER UK twins57. We found no evidence of consistent
genotypic differences between MZ co-twins that extended beyond
expected data missingness and that could conceivably underlie the
observed patterns (Extended Data Fig. 6a–e). Thus, we identified
two ‘non-genetic’ patterns of human phenotypic variation, Type-A
UPV, characterized by reciprocal fat and lean mass differences (a
relative adiposity) and Type-B UPV, characterized by coordinated
fat and lean mass dysregulation (a relative overgrowth).
Type-B human UPV parallels Nnat+/-p-Heavy overgrowth. We next
explored adipose tissue transcriptomic data from the same co-twin
pairs and asked whether NNAT expression was associated with
any of the human UPV clusters. Correlative analysis revealed substantial correlations between expression of several IGN1 genes and
trait discordances, including NNAT, NDN, CDKN1C and PLAGL1
(Fig. 4c). Of note, NNAT was the only gene whose expression discordance consistently correlated with both fat and lean mass discordances, features that were also specific to Type-B UPV (Fig. 4c;
dashed box). Indeed, when data were stratified by UPV sub-type,
NNAT expression associated strongly with trait discordance specifically in Type-B UPV (Fig. 4d) with expression decreased in heavier
Type-B UPV co-twins (Fig. 4e). These results suggest that NNAT
discordance (and downregulation) is a hallmark signature of Type-B
human UPV. TRIM28 expression showed no correlation with trait
discordances at either the cohort or UPV sub-type levels (Fig. 4c,d).
Thus, NNAT gene expression associates with Type-B human UPV.
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Given this clear and specific association between NNAT expression and Type-B UPV, we tested whether other key features of
the murine overgrowth polyphenism were also altered in human
Type-B UPV. For insulinemia, we found that plasma insulin discordances were highest in Type-B co-twin pairs (Fig. 4f and Extended
Data Fig. 7a). Indeed, the Type-B UPV group exhibited the clearest correlation between insulinemia and BMI levels (R2 = 0.51;
P = 2.4 × 10−13), an association that extended across the BMI spectrum (Extended Data Fig. 7b) and was well above the concordant
and Type-A UPV groups (R2 = 0.1 and R2 = 011, respectively). These
data indicate that Type-B UPV represents a unique metabolic state
where insulinemia and BMI are tightly coupled. Similarly, we found
a substantially more robust HDAC-target gene regulation associated with BMI specifically in Type-B UPV (R2 = 0.57; P = 4 × 10−16;
Extended Data Fig. 7c). Consistent with the directionality of the
Nnat+/-p mouse system, GSEA analysis showed that HDAC-target
genes were upregulated in heavier Type-B co-twins (Fig. 4g and
Extended Data Fig. 7d). Thus, hyperinsulinemia, HDAC-target gene
upregulation and lean and fat mass excesses are species-conserved
features of NNAT-associated UPV. From the clinical perspective,
these data suggest a model where NNAT buffers against emergence
of a distinct phenotypic state (polyphenism) where BMI is exceptionally coupled to insulinemia, lean and fat mass excess.
To validate these findings, we examined adipose NNAT gene
expression levels and available anthropomorphic traits in a small,
independent Danish twin cohort. The cohort consisted of 20 MZ
same-sex co-twin pairs61. As the cohort size and available traits
precluded the same clustering analysis (as in Fig. 4), we stratified the cohort into upper and lower quantiles of NNAT expression. Notably, we validated the key findings from the MuTHER
cohort: we observed increased insulinemia discordance (Extended
Data Fig. 7e) and increases in BMI discordance specifically in MZ
co-twin pairs with low NNAT expression (Extended Data Fig. 7f).
Thus, reduced NNAT expression is associated with increased
phenotypic variation in BMI and insulinemia in an independent
twin cohort.
Human UPV sub-types are epigenetically distinct. Altered epigenetic control is believed to be a key mediator of developmental
programming effects62,63. We tested whether any of our human UPV
types showed evidence of unexpected epigenetic alteration. We analyzed Infinium HumanMethylation450 DNA methylation profiles
from the same MuTHER cohort adipose samples and called differentially methylated sites between heavy versus light co-twins within
each of the four UPV groups (Extended Data Fig. 8a). Concordant
co-twins had the fewest differentially methylated sites (Extended
Data Fig. 8a,b). Type-A and Type-B discordant co-twins exhibited
hundreds of differential sites, with Type-B UPV showing the most
differently methylated sites (Extended Data Fig. 8a,b). Whereas
Type-A and Type-B UPVs are both characterized by relative
increases in fat mass (they are both relative adiposities), their adipose tissue DNA methylation profiles were clearly distinct. On average, Type-A UPV was characterized by DNA hypermethylation in
the heavier co-twin, as opposed to DNA hypomethylation in Type-B
UPV (Extended Data Fig. 8a). Further, the differentially methylated
sites of Type-A and Type-B discordant co-twins showed almost no
overlap, indicating that the two types of human phenotypic variation are truly and fundamentally distinct in their nature (Extended
Data Fig. 8b). Consistent with this idea, a search for differentially
methylated regions (DMRs), as opposed to differentially methylated sites, identified only DMRs between co-twins of the Type-B
UPV group (Extended Data Fig. 8c). Seven DMRs were identified
that reproducibly distinguish the heavy and light Type-B co-twins.
Four of the seven Type-B DMRs were hypomethylated in the heavy
co-twin. Notably, these DMRs were enriched for proximity to significant genome-wide association study (GWAS) variants for BMI,
Nature Metabolism | VOL 4 | September 2022 | 1150–1165 | www.nature.com/natmetab
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height, body fat percentage, insulin sensitivity, insulinogenic index,
diabetes and diabetes-associated cardiovascular disease (Fig. 4h).
These findings directly link NNAT and Type-B UPV to epigenetic changes near causal, metabolic disease loci. Of the 15 genes
neighboring the DMRs, a substantial fraction is involved in energy
metabolism (PARP6 and AGPAT3), transcriptional and epigenetic
regulation (TCF3 and BCOR) and associated either directly or indirectly to inherited syndromes causing lipodystrophy, hypotonia and
intellectual and heart disorders (C5orf58, AGPAT3, DNAJC19 and
HCN4). Thus, human Type-B UPV is characterized by epigenetic
regulation near human metabolic disease loci.
Type-B UPV stratifies human into distinct metabolic subgroups.
The analysis above showed that at least 30% of twin pairs in the
MuTHER cohort exhibited Type-B UPV. If Type-B UPV is truly so
common, then Type-B signatures should be readily detectable in
the general population. We tested this idea in the greater MuTHER
cohort, which includes hundreds of other individuals56,57 (Fig. 5a).
First, we generated a Type-B UPV gene expression signature by
identifying the 127 genes differentially regulated between heavy and
light co-twins in the Type-B phenotypic variation cluster, but not
differentially regulated between co-twins of the three other phenotypic variation clusters (Extended Data Fig. 9a and Methods). We
then used hierarchical clustering to stratify the cohort according to
expression of these 127, Type-B UPV genes. This analysis revealed
four reproducible clusters of individuals in the general population
(clusters 1–4 top, Fig. 5a). Individuals in clusters 2 and 3 showed
little if any coordinated regulation of Type-B UPV genes (Fig. 5a).
Clusters 1 and 4, however, showed strong coordinated regulation of Type-B UPV genes (Fig. 5a; heat map and rank analysis
(UPV-B rank)). Cluster 4 individuals were specifically enriched
in ‘heavy-like’ UPV-B transcriptome signatures, whereas cluster 1
individuals had ‘light-like’ gene expression profiles (Fig. 5a, UPV-B
rank). Notably, clusters 1 and 4 also exhibited anti-correlated expression of NNAT (Extended Data Fig. 9b) and the non-overlapping
HDAC-responsive genes. The latter indicated that the Type-B UVP
gene signature (127 genes) captures the NNAT-buffered axis of
phenotypic variation observed in the mouse and Type-B co-twins
(Fig. 5a, HDAC-signature and Extended Data Fig. 9b). Thus, we
find molecular evidence for Type-B human phenotypic variation
(or plasticity) in the general population.
Consistent with their ‘light-like’ gene expression signature, cluster 1 individuals were all not affected by obesity (Fig. 5a, obesity
annotation (top) and Extended Data Fig. 9c). In contrast, cluster 4
was enriched for individuals with obesity (Fig. 5a, obesity annotation (top) and Extended Data Fig. 9c). What is even more notable,
is that cluster 4 still included many individuals without obesity
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(~50% of the cluster) despite strong Type-B UPV and NNAT/
HDAC gene expression signatures (Fig. 5a and Extended Data
Fig. 9c). These data are consistent with the fact that approximately
62% of Type-B ‘heavy’ co-twins were also not affected by obesity
(BMI < 30). Along similar lines, there was no correlation between
Type-B gene expression and BMI within population clusters
(Fig. 5a; data within clusters are ordered from low to high BMI).
Examination of Type-B differentially methylated sites and DMRs
showed a clear enrichment of heavy-like methylation patterns in
cluster 4 individuals (Extended Data Fig. 9d). Thus, Type-B UPV
captures a dimension of population-level variation that is distinct
from obesity per se (Fig. 4b).
Type-B UPV shows an inflammatory transcriptional program.
Principal-component analysis (PCA) revealed that approximately one-third of all variation in the transcriptional dataset
correlates tightly with the Type-B UPV gene expression signature
(Extended Data Fig. 9e). This indicates that a major dimension
of population-level phenotypic variation can be attributed to the
Type-B ‘state’. To better understand the potential health implications of this finding, we analyzed the 1,000 most variable genes in
the same transcriptional dataset. Of note, these 1,000 genes were
distinct from the 127-gene Type-B UPV signature itself (Fig. 5a;
Venn diagram). Consistent with the cumulative PCA analysis, two
of the five major groups of the 1,000 most variable genes correlated strongly with the Type-B UPV gene signature (Fig. 5a′; gene
sets 2 and 5). Cluster 4 (UPV-B heavy-like) individuals expressed
high levels of inflammatory, immune and reactive oxygen species
(ROS)-associated genes (Fig. 5a′, gene set 2, and Extended Data
Fig. 9f,g). Conversely, the same individuals showed downregulation of genes involved in adipogenesis, lipid and glucose homeostasis (Fig. 5a′, gene set 5, and Extended Data Fig. 9f,g). Of note
and as with the Type-B UVP gene signature itself, gene sets 2 and
5 were not correlated with obesity within clusters. These data again
argue that the phenotypic outcomes of NNAT downregulation and
Type-B UPV are not obesity per se. Rather, Type-B UPV consists of
an altered metabolic state characterized by enhanced adipose tissue
inflammatory signatures and reduced adipogenesis, nutrient uptake
and metabolism pathway expression. Notably, cluster 4 included
both individuals with and without obesity. Type-B UPV therefore
also captures what seems to be a clear group of ‘normal weight
obesity’ (individuals with normal BMI but with hyperinsulinemia
and a highly consistent inflammatory gene expression pattern in
adipose tissue).
Type-B UPV is present in childhood. Guided by the fact that we
identified Type-B UVP in controlled genetic contexts (isogenic

Fig. 4 | Characterization of human UPV. a, UMAP projection of MZ co-twin couples, according to 35 morphometric discordances. b, Heat map of
hierarchical clustering of morphometric discordances among MZ co-twin couples. Obesity-discordant co-twins indicate that only one co-twin is affected
by obesity (BMI > 30). BMI discordant co-twins, BMI difference >5 BMI points. Dashed colored boxes highlight distinct lean mass discordances between
Type-A and Type-B UPV. c, Heat map showing the hierarchical clustering of Trim28/IGN1 genes based on the correlation of their expression discordance
and indicated phenotypic discordances. A dashed black box highlights NNAT expression discordance correlation with phenotypic discordances of those
traits that distinguish Type-A and Type-B UPV. d, Heat map showing the hierarchical clustering of Trim28/IGN1 genes based on the average correlation
of their expression discordance and all phenotypic discordances, stratified by four co-twin pairs’ clusters. e, Box-plots representing discordance of NNAT
expression, among MZ co-twins, belonging to the indicated clusters. **P = 0.0082, as assessed by one-tailed t-tests. f, Box-plots representing serum
insulin discordance, among MZ co-twins, belonging to the indicated groups. ***P = 0.0003 as assessed by one-sided Tukey’s multiple comparisons
test, following one-way analysis of variance (ANOVA). In all box-plots, lower and upper hinges indicate 25th and 75th percentiles. The upper/lower
whiskers indicate largest/smallest observation less/greater than upper/lower hinge + 1.5 ×IQR. Central median indicates 50% quantile. g, GSEA results of
HDAC-responsive gene sets between the ‘light’ and ‘heavy’ co-twins, belonging to the indicated MZ co-twins groups. Solid and transparent colored dots,
highlight either statistically significant or not significant enrichments, respectively (adjusted P value cutoff <0.01). h, Heat map showing association of
single-nucleotide polymorphisms (SNPs) and indicated phenotypic traits, within the DMRs identified between ‘light’ and ‘heavy’ Type-B UPV co-twins.
White boxes indicate no significant associations (P > 1 × 10−3), dark-red boxes indicate genome-wide significant associations (P < 1 × 10−8). Nearest are
reported. Gray and black boxes indicate the enrichment of DMR in either the ‘light’ or ‘heavy’ co-twin. BMIadjSMK, BMI adjusted by smoking; T2D, type 2
diabetes; HR, heart rate; PDR, proliferative diabetic retinopathy; PDRvNoDR, PDR versus no PDR.
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Fig. 5 | Type-B UPV signature separates adults and children into distinct phenotypic and metabolic sub-types. a, Heat map of k-means clustering of
TwinsUK individuals. Four clusters were generated according to expression of the UPV-B signature. The UPV-B ranks annotation show the median rank
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Nnat+/-p mice and MZ twins) and that the Type-B gene signature
exhibited the most striking and distinct epigenetic characteristics
(HDAC-signatures and DNA methylation signatures), we reasoned
that Type-B phenotypic variation represents a state of altered epigenetic programming initiated in early life64. We therefore repeated
our analysis using the Leipzig Childhood Adipose Tissue (LCAT)
cohort65, a childhood cohort that had equivalent (and relevant) phenotypic and adipose tissue transcriptomic data (Fig. 5b). Notably,
this analysis recapitulated all key findings above. The Type-B UPV
gene expression signature stratified the childhood cohort into four
corresponding clusters: cluster 4 children showed the strongest
Nature Metabolism | VOL 4 | September 2022 | 1150–1165 | www.nature.com/natmetab

Type-B, heavy-like gene expression patterns (Fig. 5b) and cluster
1 showed the least. Cluster 4 children showed the strongest enrichment of HDAC-responsive genes (Fig. 5b (top) and Extended Data
Fig. 9h) and reduced NNAT expression (Extended Data Fig. 9h). As
with the adult cohort, all clusters included lean individuals; clusters
3 and 4 were enriched for individuals with obesity (Extended Data
Fig. 9i); and while cluster 4 was the mostly enriched for obesity, it
again included a substantial number of lean individuals. Also, in line
with the adult analysis, cluster 4 children showed increased expression of inflammatory genes (Fig. 5b′, gene set 2, and Extended
Data Fig. 9j) and downregulation of the lipid metabolism and
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adipocyte-specific genes (Fig. 5b′, gene set 5, and Extended Data
Fig. 9j). Thus, Type-B UPV is readily observed in childhood and
stratifies children into comparable metabolic ‘states’.
Type-B UVP gene expression identifies two major obesity types.
One of the most relevant implications of these data is that they
suggest the existence of fundamentally distinct metabolic disease
sub-types and in particular, two major sub-types of obesity. To
test this idea, we performed a focused comparison of the individuals with obesity in clusters 3 and 4 (Type-B UPV gene signature
stratified) (Fig. 5c–f). Relative to cluster 3 obesity, cluster 4 individuals with obesity showed enrichment of the Type-B UPV gene
expression signature (Fig. 5a, heat map and rank analysis (UPV-B
rank)); reduced NNAT/IGN1 expression (Fig. 5c); increased
HDAC-responsive gene expression (Fig. 5c); increased inflammatory and decreased adipogenesis gene expression (Fig. 5a′, gene
set 2 and 5); and marked dysregulation of Type-B-specific DMRs
(Fig. 5d). Phenotypically, cluster 4 individuals with obesity also
exhibited consistently higher serum insulin levels (Fig. 5e); and
while not different in height, BMI or relative fat mass (fat mass
index; FatMI), cluster 4 individuals with obesity showed increased
relative lean mass (lean mass index; LeanMI) (Fig. 5f). The distinctions between cluster 3 and cluster 4 obesities were validated in the
LCAT childhood cohort for all available parameters (Fig. 5b,b′, gene
sets and Extended Data Fig. 9k). Notably, this finding suggests that
the pathophysiological consequences of Type-B UPV can already
arise in early life. The data show that cluster 3 and cluster 4 obesities
are distinct from phenotypic, transcriptional and epigenetic points
of view. Given the parallels to co-twin-based Type-B UPV, we refer
to these as Type-A obesity (cluster 3) and Type-B obesity (cluster 4).
Finally, to gain deeper insight into the transcriptional signatures
themselves and their clinically relevance, we performed cell-type
deconvolution using CibersortX66 and a recently published human
adipose tissue single-cell atlas67. The analysis, which derives estimates of relative cell-type content in the MuTHER and LCAT cohort
adipose biopsies, revealed high consistency across groups and
cohorts (Extended Data Fig. 9l). Cluster 4, notably, showed a relative increase in pre-adipocyte-to-adipocyte ratio relative to cluster
3 and increased estimates for macrophage and monocyte content.
These data are in line with the observed transcriptional signatures
and indicated that Type-B (obesity and ‘normal weight obesity’) are
characterized by increased adipose tissue inflammation and an adipocyte compartment skew toward adipose tissue progenitors.
Thus, we identify two major forms of obesity over and above the
distinct classes of human phenotypic variation.

Discussion

UPV is pervasive in complex traits and disease, even among highly
inbred animals and MZ twins. Yet we have very limited understanding of the regulatory mechanisms underpinning UPV. In precision
medicine and according to canonical models, UPV is typically
attributed to uncharacterized early (developmental programing)
or later-life environmental effects or dismissed as random biological ‘noise’. Here, we demonstrate the existence of a conserved,
NNAT-regulated axis that buffers against phenotypic variation (as
a trait) and control an overgrowth polyphenism. We show that the
same axis stratifies human populations into unique metabolic classes
and two common obesity sub-types that are distinct in their clinical presentation, transcriptional signatures and epigenetic control.
The data provide support for probabilistic, multi-stable phenotypic
canalization events being a major driver of metabolic outcomes.
One key translational question raised by these data is whether
NNAT-associated phenotypic variation and bi-stable effects are
influenced by genetic or environmental interactions. Since our
original description43, several groups41,42 generated anecdotal evidence for the existence of genetic and environmental modifiers of
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NNAT-dependent buffering of UPV. We have directly tested and
validated the idea. We observe bi-stable adiposity and bi-stable overgrowth in parallel crosses to C57BL/6J and FVB/N dams, respectively42,43. The finding indicates a substantial background genetic
interaction with the NNAT-buffered UPV axis. These data highlight
the challenge of examining and dissecting UPV effects even in mice
where genetics and environment can be controlled. So how might
plasticity axes be investigated in very large human cohorts? Aside
from building dedicated cohorts whose design accounts for both
documented and undocumented genetic, environmental and parental modifier effects, possibilities include stratification by, or GWAS
of, meta-traits (for example, all tangential Type-A versus Type-B
covarying phenotypes); and evaluation of phenotypic associations
using ‘surrogate’ polygenic risk scores, for instance composed of
variants at or near UPV-type-specific differentially expressed genes.
Based on knockout mouse data, we hypothesize that the cluster
4 metabolic state and the Type-B obesities therein, are developmentally programmed states. Incorporating probabilistic developmental
effects into models of phenotypic variation and clinical practice is
still very challenging, because we have very little understanding of
the regulatory axes or mechanisms that control phenotypic variation (as a trait), how these axes interact to generate complex traits, or
how the probabilistic regulatory mechanisms ‘switch’ and canalize
development toward altered phenotypic states and/or disease. The
finding that Nnat+/-p and Trim28+/D9 triggered effects are independent within the same in utero context is profound. It demonstrates
that multiple and distinct regulatory axes exist that act in parallel to
canalize UPV outcomes. The observation also provides proof for the
existence of multiple independent variation-buffering mechanisms
and represents an example of a tri-stable mammalian polyphenism.
They set the precedent that mammals have the genomic architecture and physiological networks to canalize at least three distinct
and reproducible developmental trajectories within the same gene–
environment context. The findings indicate that without assays such
as epigenome profiling, major precision medicine efforts will be
blind to an entire dimension of phenotypic regulation.
Identifying factors that buffer against phenotypic variation is
challenging enough; it is equally difficult to determine how probabilistic (molecular) effects mechanistically alter organism-level
physiology (such as obesity). Here, we demonstrate that the
Nnat+/-p-buffered overgrowth UPV is hyperinsulinemia dependent,
associated with islet-autonomous β-cell hyperproliferation and that
alterations in food intake only occur after overgrowth and obesity
(C57BL/6J–FVB F1s) (Fig. 2 and Extended Data Fig. 2). Notably,
this type of phenotypic variation was phenocopied in human
Type-B UPV. Together, these findings indicate that Type-B UPV
may constitute an insulin-dependent form of adiposity. While this
conclusion differs from the dogmatic view of obesity-driven hyperinsulinemia, it is consistent with reports that hyperinsulinemia may
also cause or exacerbate obesity and the suggestion that its early
treatment may prevent complications42. In support of this notion,
‘heavy’ Type-B discordant twins and Type-B individuals with obesity show downregulation of CDKN1C (Extended Data Fig. 9m,n),
a molecular effect possibly linked to congenital hyperinsulinism68.
Our data do not rule out additional physiological mechanisms
as contributors to the bimodal UPV phenotype in Nnat+/-p animals.
In association with the Coll group, we previously showed that
Nnat+/-p-triggered obesity (on C57BL/6J) is correlated with food
intake42, suggesting a potential role of the hypothalamus; however,
causality was not tested in those instances, nor was the requirement for hyperinsulinemia. Deep physiological phenotyping in
these probabilistic models is warranted though choice of assay
should not be decided lightly. Assays such as indirect calorimetry, feeding behavior and activity monitoring, in are experience
are very challenging due to both the unpredictability of each individual’s end point and therefore very high numbers required, as
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well as to notable stress sensitivity that leads to numerous dropout
animals such that the experimenter can no longer rule out a biologically biased sub-sampling. Based on experience, we would caution against descriptive or correlative experiments that do establish
causality. Nnat+/-p animals for instance have proven challenging
even for descriptive indirect calorimetry. A considerable number
of animals lose weight even under home-cage and acclimatized
conditions.
Our work shows that the islet-autonomous hyperproliferative
program (in Nnat+/-p animals) is HDAC-dependent. This result
demonstrates that HDAC modulation has a direct impact on pancreatic β-cell proliferation, which was not previously described.
HDAC activity has been previously implicated in the regulation of
adipogenesis, pancreas development, β-cell functionality and liver
metabolism69–71 and HDAC modulation has been proposed as a
potential treatment target for metabolic disease72–74. From the precision medicine perspective, our data indicate that HDAC modulation may constitute a preventative therapeutic paradigm for patients
stratified by Type-B UPV gene expression.
Altogether, this work demonstrates that in addition to genetic
and environmental factors, phenotypic outcomes in mammals are
defined by probabilistic factors with the potential to canalize multiple distinct, stable and reproducible outcomes. The data indicate
that a substantial fraction of human metabolic disease variation
(and potentially associated processes such as cancer and inflammation) are defined by such processes.

Methods

All animal experiments were approved by Institutional Animal Care and Use
Committee protocol no. 18-10-028 at VAI, USA and protocol no. MPI-ZH
2016-2019 at MPI, Germany. TwinsUK received ethical approval associated with
TwinsUK Biobank (19/NW/0187), TwinsUK (EC04/015) or Healthy Ageing Twin
Study (HATS) (07/H0802/84) studies from NHS Research Ethics Committees at the
Department of Twin Research and Genetic Epidemiology, King’s College London.
All samples and information were collected with written and signed informed
consent. The Danish Twins study was approved by the Central Scientific-Ethical
Committee of Denmark and was conducted according to the principles of the
Helsinki Declaration. Furthermore, approval was obtained from the Danish Data
Protection Agency. Informed consent was obtained from all participants. The
LCAT study was approved by the University of Leipzig Ethics Committee (265–08,
265–08-ff) and registered in the National Clinical Trials database (NCT02208141).
Written informed consent was obtained from all parents.
Trim28 and Nnat heterozygous mice. The generation of Trim28+/D9 and Nnat
heterozygous mice are described elsewhere30,43,75. All mice were maintained with
four to five siblings under controlled temperature (22 ± 1 °C) and humidity
(50 ± 10%) and a 12 h light, 12 h dark schedule. Food and water were available ad
libitum unless otherwise stated. All mice were weaned at 3 weeks of age onto a
standard chow (V1185-300 MZ-Ereich, ssniff; autoclavable mouse breeder diet
5021, cat. no. 0006540, LabDiet,). Body composition was determined using an
EchoMRI 4-in-1 (SYS-ID EF-036).
Genotyping. Ear biopsies were collected, boiled in 180 μl digestion buffer (50 mM
NaOH and 0.1 mM EDTA) at 60 °C overnight. Twenty microliters of neutralization
buffer (1 M Tris-HCl, pH 8.0) were added to stop the digestion. Two pairs of
primers, one for WT and one for mutant, were mixed separately in two reactions
with 1 μl biopsy lysate in 20 μl total volume including DreamTaq DNA polymerase
(EP0701, Thermo Fisher) and amplified by PCR for 94 °C for 1.5 min (94 °C for
30 s, 55 °C for 30 s and 68 °C for 1 min) × 31 and 68 °C for 5 min. The primers are
listed in Supplementary Table 1. The amplification products of WT (573 bp) and
mutant Nnat (545 bp) bands, were confirmed on 2% agarose gels. Methods for
genotyping the Trim28+/D9 mouse line are described elsewhere30,43.
Skeleton staining. Mice were killed, the skin and internal organs removed and
the eviscerated mice fixed in 95% ethanol overnight and stained with Alcian blue
(0.3% in 70% ethanol) for 48 h. The skeletons were incubated with 2% KOH for
48 h and stained with Alizarin red S (0.1% in 95% ethanol) overnight. The stained
skeletons were cleared in 1% KOH/20% glycerol solution for up to 1 week and
stored in ethanol/glycerol solution (1:1) before imaging.
Plasma growth factors measurement. Plasma insulin, IGF1/IGF2 and GH were
determined by ELISA according to manufacturers’ instructions (10-1247-01,
Mercodia; EMIGF1 and EMIGF2, Thermo Fisher; EZRMGH-45K, Millipore Sigma).
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Glucose tolerance test and glucose-stimulated insulin secretion. Following a 6-h
fast, mice were administered glucose (1 g kg−1) by oral gavage and blood samples
for glucose measurement were collected from the tail vein at the indicated times.
Glucose levels were measured using a OneTouch Vita glucometer. Blood samples
were collected from the cheek at the indicated times into EDTA-coated tubes to
prevent coagulation. Blood samples were centrifuged at 850g for 20 min at 4 °C to
collect plasma. Plasma insulin was measured by ELISA (10-1247-01 or 10-1249-01,
Mercodia).
Mouse islet isolation and spheroid formation. Mice were killed with CO2 and
dissected according to standard procedures. The common bile duct was tied off
with a thread, so perfusion buffer would flow to the pancreas rather than the liver.
The pancreas was perfused with 5 ml collagenase digestion buffer (HBSS, 10 mM
HEPES and 2 mg ml−1 collagenase 4 from Worthington, cat. no. LS004189) through
the sphincter of Oddi. The perfused pancreas was placed in 2 ml collagenase
digestion buffer and incubated for 30 min at 37 °C. After incubation, the tube was
mixed by inversion 30 times. Then, 40 ml of quenching buffer (HBSS, 24 mM
HEPES and 5 mg ml−1 BSA) was added to stop the collagenase activity. The tube
was centrifuged at 200g for 3 min at 4 °C to form a cell/tissue pellet. The pellet was
resuspended with 25 ml quenching buffer and run through a 420-µm strainer to
remove undigested material. The clarified supernatant was then passed through
a 70-µm strainer to collect the islets from the bulk solution. The islets were
transferred into a cell culture dish containing RPMI medium (Gibco, 11875093)
by inverting the strainer and dipping it in medium. The dish was placed in a 5%
CO2 incubator at 37 °C overnight. The following day, islets were removed from the
culture dish with a P10 pipet and transferred into a fresh RPMI dish. Recovered
islets were incubated in a 5% CO2 incubator at 37 °C for another 2 days to allow
islet metabolism to normalize. Then, 100 µl of islet suspension were mixed with
500 µl warm accutase (A6964-100ML, Sigma) and incubated for 2 min at 37 °C
to dissociate islets into single cells. Cells were stained with DAPI and sorted by
FACS to recover (DAPI-negative) live cells. Approximately 2,000 live cells were
seeded per well in a 96-well spheroid plate (Corning, CLS4520-10EA) and the plate
incubated in a 5% CO2 incubator for 3 days at 37 °C until spheroids formed.
Glucose-stimulated insulin secretion ex vivo. Krebs Ringer buffer (140 mM NaCl,
3.6 mM KCl, 0.5 mM NaH2PO4, 0.2 mM MgSO4, 1.5 mM CaCl2, 10 mM HEPES
and 2 mM NaHCO3) and BSA (0.5 %) was prepared freshly on the treatment day
and pH adjusted to 7.4. The 2.8 mM glucose and 16.7 mM glucose solutions were
prepared with fresh Krebs Ringer buffer. Isolated islets or formed spheroids were
transferred into 100 µl of the 2.8 mM glucose solution and incubated at 37 °C for
30 min. Then, the islets or spheroids were transferred into another well with 100 µl
2.8 mM glucose solution and incubated at 37 °C for 1 h for the basal release. Finally,
the islets or spheroids were transferred into another well with 100 µl 16.7 mM
glucose solution and incubated at 37 °C for 1 h for the glucose-stimulated release.
Total insulin content. Intact pancreata were weighed, cut into small pieces and
incubated with 0.18 M HCl in 70% ethanol overnight at 4 °C. The resulting mixture
was transferred to 1.5-ml microfuge tubes and centrifuged at 850g for 5 min at
room temperature. The clarified supernatant was transferred to a new tube and
stored at −20 °C until use. Insulin content was determined via ELISA according to
the manufacturer’s instructions (10-1247-01, Mercodia).
Streptozocin administration and insulin pellet restoration. Five-week-old mice
received a one-time i.p. injection of STZ (300 mg kg−1, Sigma, S0130-1G). Four days
and again 1 month after STZ treatment, insulin pellets (Linplant, Linshin) were s.c.
implanted on the back of the animals (one pellet per 20 g body weight) as per the
manufacturer’s instructions.
EdU proliferation. Primary islets in RPMI medium (10% FBS, 50 IU ml−1
penicillin, 50 μg ml−1 streptomycin, 0.25 μg ml−1 amphotericin B and 50 mg ml−1
gentamicin) were stained with 10 μM EdU using a fluorescence microscopy
protocol kit following the manufacturer’s instructions (iFluor 488, ab219801,
Abcam). We used an A1 Plus-RSi laser scanning confocal microscope (Nikon)
and z-stack function to capture sequential images of the islets and reconstruct
their three-dimensional volume. The total volume of EdU-incorporated cells
was then calculated with an ImageJ macro (https://visikol.com/wp-content/
uploads/2019/02/Visikol-Measure-Volume-Macro.ijm).
Islet RNA extraction, library preparation and sequencing. Total RNA was
extracted from isolated islets using the QIAGEN RNeasy Micro kit (cat. no.
74004). Libraries were prepared from 10 ng of total RNA. Total RNA material
was converted to dsDNA using the SMART-Seq v.4 Ultra Low Input RNA kit for
sequencing, v.091817 (Takara Bio). Illumina Nextera DNA Flex kit (Illumina) was
used to convert the complementary DNA into Illumina-compatible sequencing
libraries. The quality and quantity of the finished libraries were assessed using
a combination of Agilent DNA High Sensitivity chip (Agilent Technologies),
QuantiFluor dsDNA System (Promega) and Kapa Illumina Library Quantification
qPCR assays (Kapa Biosystems). Individually indexed libraries were pooled
and 50-bp, paired-end sequencing was performed on an Illumina NovaSeq6000
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sequencer using an S1, 100 cycle sequencing kit (Illumina). Each library was
sequenced to an average raw depth of 30 M reads. Base calling was conducted by
Illumina RTA3 and the output of NextSeq Control Software was demultiplexed and
converted to FastQ format with Illumina Bcl2fastq v.1.9.0.
Mouse transcriptomic analysis. We performed bulk messenger RNA-seq on
primary islets and adipocytes taken from Nnat+/-p-Light, Nnat+/-p-Heavy mice and
WT littermates. Raw sequences were aligned to mouse reference genome GRCm38.
p6 with the snakePipes2 RNA-seq pipeline76. Differential expression of the raw
counts was performed using DESeq2 (ref. 77). GSEA of DEG results was performed
with fgsea78. Enrichment maps were generated in Cytoscape79 from results of
6-week-old Nnat+/-p-Light versus Nnat+/-p-Heavy MSigDB C2 CGP GSEA. We
also performed bulk mRNA-seq on primary islets from early-stage (3-week-old)
Nnat+/-p-Light and Nnat+/-p-Heavy-like mice and WT littermates. Differential
gene expression analysis was performed as described above. Samples were batch
corrected using ComBat and normalized count matrices were inspected using
PCA. Nnat+/-p-Heavy enriched leading-edge genes from HDAC-related gene sets
were assessed at early and late-stage expression profiles to be represented on the
heat map. The contribution of the HDAC-signature to the overall gene expression
variation was evaluated based on the PCA. The principal components (PCs) from
the PCA were ordered for their association to the HDAC-signature (mean of
contributions to PCs for the genes belonging to the signature) and the top four
correlated were subset (the inflection point of the ordered PCs). The cumulative
contribution of these PCs to gene expression variation in the dataset was visualized
and compared to the overall contribution from all PCs.
HDACi and HATi treatment. Islets were isolated from 7–8-week-old animals
and cultured ex vivo in RPMI medium (added 10% FBS, 50 IU ml−1 penicillin,
50 μg ml−1 streptomycin, 0.25 μg ml−1 amphotericin B and 50 mg ml−1 gentamicin)
for 2 days to reach steady state. Islets were then treated with 500 nM HDACi (TSA)
or 500 mM HATi (C646) for 1 day, followed by a 2-d EdU incubation (iFluor 488,
Abcam) to track DNA replication.
Immunochemistry and H&E staining. Insulin (A0564, DAKO, 1× ready to use)
and H&E staining were performed on sequential, 5-μm paraffin thin sections
fixed in 4% phosphate-buffered formalin. Insulin immunohistochemistry was
performed on an Agilent Autostainer Link 48 instrument as per the manufacturer’s
instructions. Stained thin sections were digitized with an Aperio ScanScope slide
scanner fitted with a ×20 objective (Leica). For each animal, we imaged three
insulin and three H&E thin sections. Positively stained β-cells in each thin section
were quantified with Genie (Leica) software. Reported β-cell-positive areas are the
average from four animals per group and three thin sections per animal (n = 12
thin sections). We quantified apoptosis events by using the TUNEL assay kit,
HRP-DAB (ab206386, Abcam) on pancreatic sections from 16-week-old animals.
Immunofluorescence. Paraffinized sections were heated, deparaffinized with
xylene and rinsed in water. Antigen retrieval was performed by heating the
slides at 95 °C for 20 min in Tris-EDTA, pH 9.0. Specimens were blocked in
5% goat serum PBST (0.05% Tween 20) and incubated overnight with insulin
primary antibody (A0564, DAKO; 1:50 dilution) and Ki-67 primary antibody
(ab15580, Abcam; 1:200 dilution); glucagon primary antibody (G2654, Sigma;
1:500 dilution); and somatostatin primary antibody (ab30788, Abcam; 1:200
dilution). Fluorochrome-conjugated secondary antibodies (Alexa Fluor 488,
anti-rabbit; Alexa Fluor 555, anti-guinea pig; Alexa Fluor 647, anti-rat; Alexa Fluor
488, anti-mouse; 1:500 dilution, Invitrogen) were then added to each slide and
incubated for 2 h at room temperature. Slides were rinsed three times for 10 min
each in PBST buffer and air dried. A drop of VectaShield mounting medium
(containing DAPI; H-1200, Vector Laboratories) and coverslip were applied to each
slide and slides cured overnight at 4 °C in the dark before image acquisition. Images
were acquired using an A1 Plus-RSi laser scanning confocal microscope (Nikon).
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samples were obtained from skin punch biopsies. Gene expression profiles were
generated using Illumina’s whole genome expression array (HumanHT-12 v.3)
and are available from the ArrayExpress archive under the repository no.
E-MTAB-1140. For expression arrays, the original authors57 used multiple technical
replicates for each sample, which were all randomized before hybridization
and replicates run on different BeadChips. Expression signals were normalized
separately per tissue, with quantile normalization of the replicates of an
individual followed by quantile normalization across all individuals. The authors
acknowledged that their approach does not adjust for shared covariance due to
technical factors that may influence subsequent analysis, but previous efforts
indicate that the impact on the result seemed to be minor80. Expression data were
corrected for technical batch effect using ComBat81 and distributions of identified
UPVs and individuals’ clusters among batches did not show specific enrichment.
Differential expression analysis and GSEA were performed using limma82 and
fgsea78, respectively. The differential expression analysis was performed using
age as a covariate in the model. Cell-type deconvolution was performed using
CibersortX66 and a recently published single-cell atlas of human white adipose
tissue67 was used as a signatures reference.
Monozygotic co-twin analysis. To maximize the number of co-twin couples in the
analyses (n = 153), we excluded the waist, hip and waist-to-hip ratio measurements,
which were not available for ~one-third of the cohort. Discordance indices were
calculated as the difference of the log-transformed values between co-twins for
each measurement, after ordering the co-twins according to their BMI. Likewise,
we calculated gene expression discordance from normalized expression array
counts. We used a graph-based clustering approach from Seurat58 for unbiased
clustering of co-twin pairs according to their morphometric discordances. Heat
maps of morphometric discordances were generated with ‘pheatmap’ (https://
cran.r-project.org/web/packages/pheatmap/index.html) by clustering discordances
based on Euclidean distances, a complete agglomeration method and rows
scaling. Correlations between gene expression and phenotypic discordances
were determined by Spearman correlation and reported as the −log10(P). When
performing the same analysis on the identified co-twin clusters, the average of
P values from all Spearman correlations for a single gene was reported.
Danish Twins cohort. The Danish Twins cohort used in this study consists of 160
elderly individuals (88 females and 72 males), aged between 63 and 83 years.
The cohort includes 20 MZ and 21 DZ same-sex co-twin pairs and is part of a
larger study61. RNA samples were obtained from subcutaneous adipose tissue
biopsies and NNAT expression was measured by qRT–PCR analysis, as previously
reported43. The MZ co-twin pairs were divided into halves according to their
average NNAT expression level. Like the TwinsUK cohort, we calculated serum
insulin and BMI discordance among MZ co-twins (as log2(fold change) and
difference, respectively). Gaussian finite mixture modeling from the Mclust tool83
was used to separate insulin-concordant and -discordant co-twin pairs. The
proportions of insulin-concordant and -discordant co-twins among NNAT-lowand NNAT-high-expressing couples were visualized. The distributions of BMI
discordances among NNAT-low- and NNAT-high-expressing couples were
compared for homogeneity of variances using the Bartlett’s test.

qRT–PCR. Total RNA was extracted using TRI Reagent (Sigma) and reverse
transcribed into cDNA using a commercially available kit (43-688-14, Applied
Biosystems). Nnat and Hprt transcripts were quantified using TaqMan gene
expression assays with validated probes (Life Technologies). All probes are listed
in Supplementary Table 1. All qPCR reactions were performed on a 7900HT Fast
Real-Time PCR System (Applied Biosystems). Thermal cycling conditions for
all genes included 2 min at 50 °C, 20 s at 95 °C and 40 cycles of 95 °C for 1 s, 60 °C
for 20 s. Post-amplification melting curve analysis was performed to check for
nonspecific products and probe-only controls were included as negative controls.
Threshold cycles (Ct values) were normalized to Hprt within each sample to obtain
sample-specific ΔCt values (Ct gene of interest − Ct housekeeping gene). The
2-ΔΔCt values were calculated to obtain fold expression levels, where ΔΔCt = (ΔCt
treatment − ΔCt control).

DNA methylation analysis in the MuTHER TwinsUK cohort. The MuTHER cohort
contains Infinium HumanMethylation450 BeadChips array (Illumina WG-3141002) data from the subcutaneous fat derived of 648 TwinsUK participants. For
DNA methylation arrays, the original authors reported84 that tissue samples were
randomized before DNA extraction. Signal intensities were quantile normalized.
Beadchip, bisulfite-sequencing (BS) conversion efficiency (assessed with the
built-in BS conversion efficiency controls) and BS-treated DNA inputs were
shown to contribute significantly to the variation in β levels and were included
as covariates in subsequent analysis. The processed and normalized β values
were previously published57,84,85 and are available from the ArrayExpress archive
under the repository no. E-MTAB-1866. We analyzed the data using the ‘SeSAMe’
pipeline86,87. Normalized β values were analyzed by linear modeling to identify
DMRs between ‘light’ and ‘heavy’ MZ co-twins, controlling for age as a covariate
in the model. The cutoff used to define differential methylation was FP < 0.05
and effect size threshold >0.05 (DNA methylation differences under 5% were
not considered biologically meaningful). The heat map of the differentially
methylated CpGs between co-twin pairs belonging to the four different phenotypic
variation clusters was generated with ‘ComplexHeatmap’88. The genomic regions
of DMRs from the Type-B UPV co-twins were used to search for genome-wide
relevant associations between SNPs and phenotypes in the T2D Knowledge Portal
(https://t2d.hugeamp.org). When DMRs were defined by just a single nucleotide,
we searched in ±50-kb regions. All genome-wide significant associations were
reported (P = 10−8). We also visualized all the GWAS associations within our DMRs
with a P < 10−3.

Human population studies and analyses. MuTHER TwinsUK cohort. The
MuTHER cohort consists of 855 female white twins and 193 MZ co-twin pairs,
aged between 40 and 87 years56,57 and is a subset of the larger TwinsUK study55
(referred to as TwinsUK in the figures and text). Subcutaneous adipose tissue

Genotyping data analysis in the MuTHER TwinsUK cohort. The MuTHER
cohort contains genotyping data generated by Illumina 317 K, 610 k and
1 M chip arrays, from the subcutaneous fat derived of 807 TwinsUK
participants. These data are available upon request at the TwinsUK consortium
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(https://twinsuk.ac.uk/resources-for-researchers/our-data/). The genotype
annotation files were generated using IMUTE2 with 1000 Genomes Project phase
1 (interim) as a reference panel. This dataset is based on a sequence data freeze
from 23 Nov 2010; the phased haplotypes were released Jun 2011. GWAS data were
‘pre-phased’ using IMPUTE2 without a reference panel. The resulting haplotypes
were used to perform fast imputation from the 1000 Genomes Project phase 1
dataset. The imputation of TwinsUK1 (317 K chip) and TwinsUK23 (610 k and 1 M
chips) were conducted separately and merged with GTOOL. Genotyping data were
analyzed using PLINK software (v.1.9). Samples with a missing call rate exceeding
0.02 (–mind 0.02) were excluded from genetic analysis. One-way ANOVA was
conducted to determine whether overall missingness was significantly different
across UPV groups at the genome-wide level, without finding statistical relevant
differences. After removal of overly missing samples, each co-twin pair was
screened for discrepancies in genotypes to assess the extent of co-twin genetic
similarity, which accounted for >99.9% of the data. These analyses were conducted
in R (v.4.1.1) using the ‘stats’ package.
Whole MuTHER TwinsUK cohort analysis. To generalize the findings from MZ
co-twins, we included all individuals from the MuTHER cohort and analyzed
824 gene expression profiles from s.c. adipose tissues. The Type-B UPV gene
expression signature was identified by performing differential gene expression
analysis between ‘heavy’ and ‘light’ co-twins from the four concordant/discordant
clusters. We selected all the genes with a P value <0.001 and clustered them by
k-means clustering to identify the Type-B specific signature (127 total genes). We
then used the signature to stratify the TwinsUK individuals. The number of clusters
for this analysis was determined by visualizing the dispersion within each cluster
for k = 1–10 and selecting the number of clusters that represented the ‘saturation
point’ of dispersion. Cluster stability was assessed by the Jaccard’s similarity score.
These analyses were performed using the RaceID package89. The heat map of the
four k-means individuals’ clusters was generated with ‘ComplexHeatmap’88. Gene
clustering was based on Euclidean distances and Ward’s agglomeration method
of log-transformed and scaled, normalized data. The individuals were further
ordered by BMI within each group. We then ranked Type-B-specific signatures
(127 genes) for each individual. High ranks were associated with a ‘heavy-like’
Type-B transcriptional profile. The median of ranks from all UPV-B genes was
plotted for each individual. The contribution of the Type-B-specific gene signature
to overall gene expression variation in the cohort was evaluated as follows. PCA
was performed on the gene expression profiles of all individuals. The 824 PCs
were ordered for their association to the Type-B gene expression signature (mean
of contributions to PCs of the genes belonging to the 127-gene signature) and
the top 25 correlated components were subset (inflection point of the ordered
PCs). The cumulative contribution of the top 25 PCs to gene expression variation
in the cohort was visualized and compared to the overall contribution from all
824 PCs. The HDAC-signature annotation reported in the heat map was derived
as follows: first, we performed GSEA of HDAC-related gene sets between the
‘heavy’ and ‘light’ co-twins belonging to the Type-B phenotypic cluster. Next,
we retrieved the leading-edge genes (genes driving the gene sets’ enrichment),
from the ‘heavy’-enriched HDAC-related gene sets, which then defined the
HDAC-signature. Annotations in the heat map show the average expression of the
HDAC-signature genes for each individual. The unbiased transcriptional analysis
among the four individuals’ clusters was based on the top 1,000 most variable genes
among all the samples (heat map shows only the genes for which we can detect
expression in the LCAT cohort). GO and pathway analysis were performed with
‘clusterProfiler’90 against the GO, KEGG and MSigDB databases. For the metabolic/
morphologic characterization of the individuals’ and obesity clusters, the serum
insulin levels were adjusted on BMI and the fat and lean mass normalized on the
squared height, generating FatMI and LeanMI, respectively.
The LCAT cohort. The LCAT cohort consists of female and male white children
aged 0–18 years who underwent elective orthopedic surgery, herniotomy/
orchidopexy or other surgeries65. Exclusion criteria were severe diseases
and medication that might affect adipose tissue biology, such as diabetes,
generalized inflammation, malignant diseases, genetic syndromes or permanent
immobilization. BMI data were standardized to age- and sex-specific centiles by
applying German reference data and are represented as BMI SDS91. Overweight
and obesity are defined by a cutoff of 1.28 and 1.88 SDS (90th or 97th centile),
respectively. Subcutaneous adipose tissue samples were excised during surgery,
washed three times in PBS and immediately frozen in liquid nitrogen for RNA
isolation. For RNA-seq, gene expression profiles were generated as previously
described43. Differential expression and GSEA were performed using DESeq2
(ref. 77) and fgsea78, respectively. Normalized counts were corrected for both
age and sex confounders with ComBat81. For global gene expression analysis on
individuals, 61 profiles from s.c. adipose tissues were analyzed (34 males and 27
females). The number of clusters selection and the heat map generation were
performed as in the adult cohort. The heat map in Fig. 5 shows the Type-B specific
gene clustering (top) and the same variable genes as in the TwinsUK cohort
(bottom). For the metabolic/morphometric characterization of the individuals’ and
obesity clusters, standardized (SDS) measurements and fasting serum insulin levels
normalized on BMI SDS were visualized.
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Statistics. In both human and mice analyses, equality of variances and means
were assessed by Levene’s test and Student’s t-tests, respectively (unless otherwise
specified). We used one-way ANOVA followed by Tukey’s honestly significant
difference test (where appropriate and as indicated) for multiple comparison
testing. In the mice body composition data analysis, the separation into discrete
clusters was tested by Gaussian finite mixture modeling using the Mclust tool83.
A supervised analysis was performed to identify the best model describing the
WT as a single reference cluster. Next, the same model was applied on data
from other genotypes. All data are expressed as mean ± s.e.m., unless otherwise
specified. Correlations were tested by linear regression, unless otherwise specified.
All reported P values are two-tailed, unless stated otherwise, where P ≤ 0.05 was
considered to indicate statistical significance. Calculations to evaluate the power
to detect an effect given the sample size in mouse studies, were performed with
bifurcatoR (https://github.com/VanAndelInstitute/bifurcatoR). Mouse studies were
designed to reach 95% power to detect effect size.
Reporting summary. Further information on research design is available in the
Nature Research Reporting Summary linked to this article.

Data availability

RNA-seq data from both mouse primary islets and subcutaneous adipose tissue
of the LCAT cohort, have been deposited to Gene Expression Omnibus and
are publicly available under the accession codes GSE205740 and GSE205668,
respectively. They are collected under the GSE205741 super-series. Gene expression
and DNA methylation profiles by whole genome arrays from subcutaneous adipose
tissue of the MuTHER TwinsUK cohort have been deposited to Array Express and
are publicly available under the accession codes E-TABM-1140 and E-TABM-1866,
respectively. Morphometric and genotypic data of the MuTHER TwinsUK cohort
are available upon request at https://twinsuk.ac.uk/resources-for-researchers/
access-our-data/. The MSigDB is available at http://www.gsea-msigdb.org/gsea/
msigdb. Source data are provided with this paper.

Code availability

No custom code or mathematical algorithm were generated in this report. All
publicly available codes and tools used to analyze the data are reported and
referenced in the Methods and the Reporting Summary.
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Extended Data Fig. 1 | See next page for caption.
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Extended Data Fig. 1 | Paternal but not maternal Nnat deletion causes bi-stable overgrowth. a, The body composition was shown for 16 weeks old of F1
female wild-type and Nnat+/-p animals from Nnat+/-p x FVBN/J crosses. b-c, The body composition was shown for 16 weeks old F1 male (b) and female (c)
wild-type and Nnatm/+ animals from Nnat-m/+ x FVBN/J crosses. d-e, The Nnat+/-p male (d) and female (e) body composition was plotted for the Nnat+/-p
colony in the vivarium, VAI, U.S.A. f, Genotyping (DNA) was confirmed in the indicated Nnat+/-p morphs and WT littermate. Nnat mRNA expression was
confirmed in metabolic tissues (adipocytes, islet, pituitary gland and hypothalamus) from male Nnat+/-p mice. Nnat mRNA expression was measured from
two independent sets of littermate matched animals. The experiments were repeated independently 3 times with similar results. g, Body composition was
measured by EchoMRI on 16-week-old wild-type (WT), Trim28D9/+, Nnat+/p and Nnat+/p Trim28D9/+ male progeny from F1 of B6.Nnat+/-p x FVB.Trim28D9/+
crosses. Contour plots highlight main clusters identified by Gaussian finite mixture modeling. h, Trim28 and Nnat (as control) gene expression were shown
from islet (left) and adipocyte (right) transcriptomes from Nnat+/-p colony. Each group had at least 3 animals. All data were plotted as mean ± SEM, ns (not
significant), **** (adjusted p < 0.0001) by one-sided Tukey’s multiple comparisons test.
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Extended Data Fig. 2 | See next page for caption.
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Extended Data Fig. 2 | Nnat+/-p-Heavy morphs exhibit accelerated post-weaning growth kinetics associated with hyperinsulinemia. a, Birth weight
was measured for Nnat+/-p male newborns. Each group had at least 22 animals. Data are presented as mean ± SEM. b, Fat (top) and lean (middle) mass
deposition between 4 to 7 weeks were plotted for male Nnat+/-p colony. Daily food intake (button) was measured and the average daily food intake were
calculated per week between 4 to 7 weeks for male Nnat+/-p colony. All data were plotted as mean ± SEM. Adjusted p-values by one-sided Tukey’s multiple
comparisons test. Top panel *** p < 0.0001; middle panel * p = 0.016, *** p < 0.0001; lower panel * p = 0.0019. c, Daily food intake normalized to body
weight (top) and body weight deposition normalized to average daily food intake per week (button) between 4 to 7 weeks were plotted for male Nnat+/-p
colony. All data were plotted as mean ± SEM. Adjusted p-values by one-sided Tukey’s multiple comparisons test. Lower panel * p = 0.0104, ** p = 0.002,
*** p < 0.0001. d, Circulating growth factors (insulin-like growth factor 1, IGF1; growth hormone, GH; and insulin, INS) were detected in plasma of Nnat+/p
males and WT littermates at 4 and 6 weeks of age. Each group had at least 3 animals. All data were plotted as mean ± SEM. Adjusted p-values by onesided Tukey’s multiple comparisons test. ** p = 0.0001, *** p < 0.0001.
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Extended Data Fig. 3 | Nnat+/-p-Heavy morphs exhibit normal glucose tolerance and islet functionality. a, H&E staining was performed to locate islets
(light pink areas, arrows) in Nnat+/-p pancreata. Scale bar, 500 µm. The experiment was repeated independently 3 times with similar results. b, Islet area
was quantified as percent of the entire pancreas area. Each group had 3 thin sections from at least 6 animals. All data were plotted as mean ± SEM,
*** (adjusted p < 0.0001) by one-sided Tukey’s multiple comparisons test. c, Total insulin content was extracted from whole pancreata, normalized to
total insulin in WT littermates. Each group had at least 5 animals. All data were plotted as mean ± SEM, *** (adjusted p = 0.0008) by one-sided Tukey’s
multiple comparisons test. d, Glucagon and somatostatin staining was performed on Nnat+/-p pancreata. Scale bar, 100 µm. The experiment was repeated
independently 3 times with similar results. e, Cell death (apoptosis) event was examined via TUNEL assay in the pancreatic section from Nnat+/-p and
WT littermates at 16 weeks old. DNase treated sample as positive control from the same animals. The black circle heights the islet area. Each group had
at least 3 animals. Scale bar, 100 μm f, Basal insulin secretion was measured from size-matched β-cell spheroids. Each group had 8 spheroids. All data
were plotted as mean ± SEM. g, h Glucose-stimulated insulin secretion assays were performed on primary islets (g) and spheroids (h) from 16 weeks
old Nnat+/-p and WT littermates. 2.8 mM glu.: 2.8 mM glucose and 16.7 mM glu.: 16.7 mM glucose. At least 6 primary islets and 4 spheroids were in each
group. All data were plotted as mean ± SEM. i, Oral glucose tolerance test (OGTT) was performed in 16 weeks old Nnat+/-p and WT mice (n = 4-5) fasted
for 6 hours and showed relatively normal glucose tolerance in Nnat+/-p-Heavy morphs. All data were plotted as mean ± SEM. j, Growth trajectories for
untreated and STZ-treated Nnat+/-p animals and WT littermates between 4 and 12 weeks of age. All data were plotted as mean ± SEM.
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Extended Data Fig. 4 | Dysregulated HDAC-related transcriptome precedes the Nnat+/-p-overgrowth. a, Venn diagram of differential gene expression
analyses of islets transcriptome of 6 weeks old mice comparing between Nnat+/-p-Heavy, Nnat+/-p-Light morphs and WT littermates. b, GSEA results of
HDAC-responsive gene sets between the Nnat+/-p-Light and Nnat+/-p-Heavy morphs, showing a specific enrichment in the latter. Solid and transparent
colored dots, highlight either statistically significant or not significant enrichments, respectively (adjusted p-value cutoff < 0.05). c, Gene expression
(Z-score) comparison was performed for HDAC gene set leading-edge genes between Nnat+/-p-Heavy-like and Nnat+/-p-Light-like morphs (early stage)
and Nnat+/-p-Heavy and Nnat+/-p-Light morphs (late stage). **** (p ≤ 0.001) as assessed by two-tails t-tests. In all box-plots, the lower and upper hinges
= 25th and 75th percentiles. The upper/lower whiskers = largest/smallest observation less/greater than upper/lower hinge + 1.5 * IQR. Central median
= 50% quantile. d, Estimate of the contribution of the HDAC-responsive genes, to the overall transcriptional variability between WT, Nnat+/-p-Heavy and
Nnat+/-p-Light mice. Following PCA, the dotplot shows either the cumulative contribution of all principal components (PCs) to gene expression variation
(black dots/line), or the contribution of the top four PCs (red dots/line), mostly associated with the HDAC-leading-edge genes from (b). The cumulative
contribution of these four PCs is describing 58.7% of total gene expression variation.
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Extended Data Fig. 5 | See next page for caption.
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Extended Data Fig. 5 | Characterization of the concordant/discordant MZ co-twin groups. a, Boxplot showing the inter-quartile ranges (IQR) of co-twin
discordance indices for all the available features in either MZ or dizygotic (DZ) co-twins. b, Boxplot showing the MZ co-twin discordance indices for the
indicated morphometric features, in the concordant/discordant groups identified. A horizontal dashed line highlights zero values of the discordance index
(that is, concordance). Vertical dashed lines separate fat/lean/total mass and percentage of fat from the indicated body parts. c, UMAP projection of MZ
co-twin couples from TwinsUK (n = 153), according to 35 morphometric discordances. Each observation represents a twin pair, colored by the whole-body
fat (above) or lean (below) mass discordance (calculated as the difference between log-transformed measurements). The different shapes of the co-twin
pairs represent the identified groups, as indicated. Dotted red/green lines highlight the Type-A and Type-B UPV and show their differences with respect
to lean mass discordance. d, Box-plots representing the average height, between the ‘light’ and ‘heavy’ MZ co-twins, belonging to the indicated groups.
Solid horizontal lines represent medians. The p-value is calculated by ANOVA. e, Boxplot showing the MZ co-twin discordance indexes for the indicated
morphometric features, after height-normalization, in the concordant/discordant groups identified. A horizontal dashed line highlights the zero value of
the discordance index (that is, concordance). Box plots in (b,d,e) show the lower and upper hinges = 25th and 75th percentiles. The upper/lower whiskers
= largest/smallest observation less/greater than upper/lower hinge + 1.5 * IQR. Central median = 50% quantile.
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Extended Data Fig. 6 | See next page for caption.
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Extended Data Fig. 6 | UPV groups are not determined by genetic differences between MZ cotwins. a, Violin-plots showing the distribution of missing
data (as percentage of the total) among individuals’ genotypes, stratified by UPV groups. This data show that the degree of genome wide missingness
is not correlated to UPV groups. b, Table summarizing the amount of genetically identical loci among MZ cotwins and genetic differences, only due to
missing data. c, Barplot summarizing the data in table b. MZ cotwins were identical on > 99.9% of the analyzed loci and differences due to missing data
account on average for ~ 0.06% of the total data, among all UPV groups. d, Heatmaps showing the distribution of SNPs that resulted different between MZ
cotwins, only due to missing data. On the left, the cotwin pairs are ordered by the UPV sub-types. On the right, they are ordered according to hierarchical
clustering. These data show that neither the degree of missingness, nor the specific genomic positions of missing data showed any correlation to UPV
sub-types. e, Same as in a, on the indicated genesets. These data show no specific enrichment of missingness in any UPV group, nor any genesets, arguing
against evidence for genotypic differences underlying the detected transcriptional signatures. All p-values as assessed by ANOVA.
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Extended Data Fig. 7 | See next page for caption.
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Extended Data Fig. 7 | Type-A and Type-B UPV show specific metabolic and molecular profiles. a, UMAP projection of MZ cotwin couples form the
TwinsUK (n = 153), according to 35 morphometric discordances. Each dot represents a cotwin pair, colored by their serum insulin level discordance
(calculated as the difference between log-transformed measurements). The different shapes of the cotwin pairs represented the identified groups. Dotted
red/green lines highlight the Type-A and Type-B UPV and show the increase insulin levels (that is, relative hyperinsulinemia) in Type-B ‘heavy’ cotwins.
b,c, Scatterplots showing the correlation between BMI and insulin level (b) or the HDAC-signature expression (c), in the indicated cotwin groups. Both
showing stronger correlation in the Type-B UPV cotwins (BMI/insulin: R2 = 0.51, p-value=2.4-13, BMI/insulin: R2 = 0.57, p-value=4-16). R2 and p-values as
calculated by fitted linear regression models. d, Gene set enrichment analysis (GSEA) results of HDAC-related gene sets between the ‘light’ and ‘heavy’
cotwins, belonging to the Type-B UPV group. Gene sets specifically enriched in ‘heavy’ cotwins of the Type-B UPV cluster are shown. NES = normalized
enrichment score; padj = adjusted p-value. e, Pie-charts, showing the distribution of insulin-concordant/discordant MZ cotwin pairs, from the Danish twin
cohort, in either low- (blue chart), or high-NNAT expressing couples (yellow chart). The definition of insulin-concordant/discordant couples was obtained
by Gaussian finite mixture modeling (see Methods section). f, Box- and violin-plots of BMI discordance distributions, represented as inter co-twin
differences in the Danish twin cohort. Solid horizontal lines and black points represent means and medians in the box-plots, respectively. * p-value = 0.03,
as assessed by the Bartlett’s test of homogeneity of variances. Blue and yellow triangles represent co-twin pairs expressing averaged low and high NNAT
levels, respectively. In box-plots, the lower and upper hinges = 25th and 75th percentiles. The upper/lower whiskers = largest/smallest observation less/
greater than upper/lower hinge + 1.5 * IQR. Central median = 50% quantile.
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Extended Data Fig. 8 | Type-A and Type-B UPV are associated to distinct DNA methylation patterns. a, heat map showing the differentially DNA
methylated sites among ‘heavy’ and ‘light’ cotwins belonging to the indicated groups identified in the TwinsUK cohort. SeSAMe cutoffs: adjusted
p-value < 0.05; effect size > 0.05. Dark-gray and black boxes highlight DNA methylation enrichment in either the ‘light’ or ‘heavy’ cotwin, respectively.
b, Venn diagram showing the overlap between differentially DNA methylated sites from the indicated cotwin groups and highlighting the specificity of
these epigenetic profiles. c, Barplots showing the amount of differentially methylated regions (DMRs) among ‘heavy’ and ‘light’ cotwins belonging to
the indicated groups identified in the TwinsUK cohort. Only in Type-B UPV, DMRs were detected. Dark-gray and black bars highlight DNA methylation
enrichment in either the ‘light’ or ‘heavy’ cotwin, respectively.
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Extended Data Fig. 9 | See next page for caption.
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Extended Data Fig. 9 | Characterization of adults’ and childrens’ clusters. a, Heat map of hierarchical clustering of DEGs between cotwins belonging
to indicated groups. b, Boxplot showing the mean expression of HDAC-signature (above) or NNAT (below), among indicated clusters. p-values (2.2e16; 1e-10) from ANOVA. c, Barplot showing obesity distribution among clusters. d, Boxplot showing normalized beta values for differentially methylated
sites (above, p = 2.2e-16 and 2.2e-16) or regions (below, p = 0.0005 and 2.6e-8), among cotwins. ‘Heavy’- and ‘light’ enriched DNA methylated sites
are reported. *** (p ≤ 0.001) from two-tails t-tests. e, UPV-B genes estimate of contribution to overall transcriptional variability in the TwinsUK cohort.
Cumulative contribution of all principal components (black dots/line) and contribution of the most UPV-B-associated PCs (red dots/line) are reported.
f, Boxplot showing mean expression of genes belonging to five genesets form Fig. 5b, among clusters. *** (p = 2.2e-16) from one-sided Tukey’s multiple
comparisons test, following significant ANOVA. g, Complete gene ontology and pathway enrichment analysis for the 5 genesets from the heat map of
TwinsUK individuals. h, Boxplot showing mean expression of HDAC-signature (above) or NNAT (below), among the clusters of the LCAT cohort. p-values
from ANOVA. i, Barplot showing obesity distribution, among cluster in the LCAT cohort. j, Boxplot showing mean expression of genes belonging to the
five genesets form Fig. 5b, among clusters in the LCAT cohort. * (p = 0.004), *** (p = 2.2e-16) from one-sided Tukey’s multiple comparisons test, following
significant ANOVA. k, Box-plots showing distributions of serum insulin levels normalized on BMI-SDS, among children with obesity belonging to indicated
clusters. ** (p = 0.0016) from two-tails t-tests. l, Barplots showing average cell-type compositions among transcriptional profiles of individuals belonging
to indicated clusters. ASPC = adipose stem and progenitor cells, LEC = lymphatic endothelial cells, SMC = smooth muscle cells. m-n, Box-plots showing
CDKN1C expression between ‘light’ and ‘heavy’ Type-B UPV cotwins (m) and Type-A/-B obesities (n). In all box-plots, lower and upper hinges = 25th
and 75th percentiles. The upper/lower whiskers = largest/smallest observation less/greater than upper/lower hinge + 1.5 * IQR. Central median = 50%
quantile. p-values from one-tail (m) or two-tails (n) t-tests.
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